TDOC Teladoc Health, Inc. Common Stock
$6,60
Kurs · Aug 18, 2026
Fundamentaldaten per Jul 30, 2026
52W-Spanne
$4–$10
40% of range
Analystenbewertung
HOLD
31 analysts
Kursziel
$8
+18% upside
P/E (TTM)
-5.9
ROE
-14.3%
Nettogewinnmarge
-7.9%
Über Teladoc Health, Inc. Common Stock Unternehmensübersicht von Wikipedia
Teladoc Health, Inc. ist ein US-amerikanisches Unternehmen für Telemedizin und virtuelle Gesundheitsfürsorge mit Sitz in Purchase im Bundesstaat New York. Zu den primären Dienstleistungen gehören Telemedizin, medizinische Gutachten, KI und Analytik sowie lizenzierbare Plattformdienste. Teladoc Health nutzt insbesondere Telefon- und Videokonferenzsoftware sowie mobile Apps, um medizinische Fernbetreuung auf Abruf anzubieten. Zum Unternehmen Teladoc Health gehören verschiedene Marken. Die Dienste von Teladoc Health waren 2019 in über 130 Ländern verfügbar.
Mehr lesen
Teladoc Health, Inc. ist ein US-amerikanisches Unternehmen für Telemedizin und virtuelle Gesundheitsfürsorge mit Sitz in Purchase im Bundesstaat New York. Zu den primären Dienstleistungen gehören Telemedizin, medizinische Gutachten, KI und Analytik sowie lizenzierbare Plattformdienste. Teladoc Health nutzt insbesondere Telefon- und Videokonferenzsoftware sowie mobile Apps, um medizinische Fernbetreuung auf Abruf anzubieten. Zum Unternehmen Teladoc Health gehören verschiedene Marken. Die Dienste von Teladoc Health waren 2019 in über 130 Ländern verfügbar.
Geschäftsmodell
Teladoc Health unterteilt seine Dienstleistungen in sechs Kategorien: Plattform- und Programmdienste, Beratung und Unterstützung, medizinische Expertendienste, psychische Gesundheitsdienste, Telemedizin und integrierte virtuelle Pflege. Als Softwareunternehmen beschäftigt sich Teladoc Health mit künstlicher Intelligenz, Analytik und "lizenzierbaren Plattformdiensten". Das Unternehmen nutzt in erster Linie Telefon- und Videokonferenzsoftware, um medizinische Versorgung aus der Ferne auf Abruf anzubieten, wobei Patienten sich jederzeit bei dem Dienst anmelden können und innerhalb weniger Minuten mit einem zertifizierten, staatlich zugelassenen Arzt verbunden werden.
Die Ärzte des Unternehmens behandeln unter anderem Nicht-Notfälle wie Grippe, Bindehautentzündung, Infektionen, Nasennebenhöhlenprobleme, psychische Probleme und dermatologische Erkrankungen. Das Unternehmen verfügt über ein Netzwerk von 55.000 Experten, die in 450 medizinischen Subspezialitäten tätig sind. Während Medikamente aus der Ferne verschrieben werden können, verschreiben die Ärzte keine Narkotika oder "Lifestyle"-Mittel wie Viagra und überweisen einige Fälle an Kliniken oder Notaufnahmen.
Teladoc Health arbeitet hauptsächlich mit Versicherern und großen Arbeitgebern zusammen und generiert seine Einnahmen durch eine jährliche oder monatliche Gebühr, die pro Teilnehmer erhoben wird, sowie durch eine Gebühr für individuelle Konsultationen. Einige Unternehmen erlassen oder subventionieren die Konsultationsgebühr für ihre Mitarbeiter. Teladoc Health hat Tausende lizenzierte Ärzte und Krankenschwestern und bietet seine Dienste in verschiedenen Sprachen an.
Geschichte
Teladoc wurde 2002 in Dallas von G. Byron Brooks und Michael Gorton gegründet. Das anfängliche Geschäftsmodell von Teladoc ermöglichte es Patienten, sich jederzeit aus der Ferne mit staatlich zugelassenen Ärzten zu beraten. Unternehmen zahlten eine monatliche Gebühr für den Zugang ihrer Mitarbeiter zu diesem Dienst, während Patienten eine Pauschalgebühr für jede Konsultation zahlten, ursprünglich etwa 35 bis 40 US-Dollar. Mit Gorton als Chairman und CEO startete Teladoc 2005 landesweit und hatte bis 2007 eine Million Mitglieder gewonnen. Viele Unternehmen schlossen für ihre Mitarbeiter Verträge mit Teladoc Health ab. 2015 erfolgte der Börsengang von Teladoc Health an der New York Stock Exchange.
Sein Wachstum trieb Teladoc Health mit verschiedenen Übernahmen voran. 2015 übernahm das Unternehmen BetterHelp. In seiner damals größten Akquisition kaufte Teladoc 2017 für 440 Millionen Dollar Best Doctors, eine Firma für medizinische Beratung. 2018 wurde Advance Medical übernommen, welches Ärzte in Lateinamerika, Europa und Asien beschäftigte. Im Jahr 2019 wurde das französische Gesundheitsunternehmen MédecinDirect übernommen. Im Januar 2020 gab Teladoc bekannt, dass es eine Vereinbarung zur Zahlung von 600 Millionen US-Dollar für die Übernahme von InTouch Health getroffen hat. Im August desselben Jahres gab das Unternehmen bekannt, dass es Livongo Health für 18,5 Milliarden US-Dollar übernehmen würde.
Im Rahmen der COVID-19-Pandemie erlebte das Unternehmen einen enormen Anstieg der Nachfrage nach seinen telemedizinischen Dienstleistungen. Ende 2020 hatten die Plattformen von Teladoc Health in den Vereinigten Staaten 51,8 Millionen Mitglieder, eine Steigerung von 41 Prozent zum Vorjahr.
Im Juni 2024 übernahm Charles Divita die Rolle des CEO. Anhaltender Ergebnisdruck und ein deutlicher Kursverfall prägten die Nach-COVID-Phase bis 2025.
Marken
Folgende Marken gehören zu dem Unternehmen:
Teladoc
Advance Medical
Best Doctors
BetterHelp
HealthiestYou
MédecinDirect
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
TDOC Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$6.60
Marktkapitalisierung
$1.19B
P/E (TTM)
-5.9
EPS (TTM)
$-1.14
Umsatz (TTM)
$2.53B
Dividendenrendite
—
ROE
-14.3%
Verschuldungsgrad
—
52W-Spanne
$4 – $10
TDOC Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Configure
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz & Nettoergebnis
$2.53B
2016-12-31
→
2025-12-31
EPS
$-1.14
2019-12-31
→
2025-12-31
Freier Cashflow
$285M
2017-12-31
→
2025-12-31
Margen
-7.9%
2017-12-31
→
2018-12-31
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
Kennzahl
5-Jahres-Trend
TDOC
Peer-Median
P/E (TTM)
-5.9
39.8
P/S (TTM) (K/V (TTM))
0.5
3.5
P/B (K/B)
0.9
2.1
Price / FCF (Kurs / FCF)
4.2
—
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
Kennzahl
5-Jahres-Trend
TDOC
Peer-Median
Operating Margin (Betriebsgewinnmarge)
-10.4%
—
Net Profit Margin (Nettogewinnmarge)
-7.9%
1.5%
ROA
-6.3%
0.92%
ROE
-14.3%
3.3%
ROIC
-16.1%
—
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
Kennzahl
5-Jahres-Trend
TDOC
Peer-Median
Current Ratio (Liquiditätsgrad)
2.8
2.2
Quick Ratio
2.4
—
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Kennzahl
5-Jahres-Trend
TDOC
Peer-Median
Revenue YoY (Umsatz YoY)
-1.5%
—
Revenue CAGR 3Y (Umsatz CAGR 3J)
1.7%
—
Revenue CAGR 5Y (Umsatz CAGR 5J)
18.3%
—
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
Kennzahl
5-Jahres-Trend
TDOC
Peer-Median
TDOC Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
HALTEN
31 Analysten
- Starker Kauf 4 12,9%
- Kauf 7 22,6%
- Halten 20 64,5%
- Verkauf 0 0,0%
- Starker Verkauf 0 0,0%
12-Monats-Kursziel
19 Analysten · 2026-08-14
Median
$7.50
Jetzt
$6.60
Tief
$5.50
Hoch
$10.50
Median-Ziel
$7.50
+13,6%
Mittelwert-Ziel
$7.79
+18,0%
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
-0.01%
| Zeitraum | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|
| 30. Juni 2026 | $-0.21 | $-0.25 | 0.04% |
| 31. März 2026 | $-0.36 | $-0.32 | -0.04% |
| 31. Dezember 2025 | $-0.14 | $-0.19 | 0.05% |
| 30. September 2025 | $-0.28 | $-0.27 | -0.01% |
| 30. Juni 2025 | $-0.19 | $-0.27 | 0.08% |
| 31. März 2025 | $-0.53 | $-0.34 | -0.19% |
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | — |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | — | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| GDRX | — | 30.1 | 0.57% | 3.8% | 4.8% | — |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | — |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | — |
| PHR | — | 335.8 | 14.5% | 0.48% | 0.73% | — |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | — |
| EVH | — | -0.8 | -26.6% | -28.5% | -81.5% | — |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | $44M | |
| Cost of Revenue | · | · | · | $744M | $650M | $391M | $184M | $129M | $62M | $32M | $21M | $10M | |
| Gross Profit | · | · | · | · | · | · | · | $289M | $172M | $91M | $56M | $34M | |
| R&D Expense | $278M | $307M | $349M | $334M | $312M | $165M | $65M | $54M | $34M | $22M | $14M | $8M | |
| SG&A Expense | $432M | $435M | $465M | $450M | $438M | $507M | $164M | $117M | $80M | $49M | $43M | $18M | |
| Operating Expenses | $2.79B | $3.59B | $2.85B | $16.06B | $2.30B | $1.60B | $634M | $489M | $309M | · | · | · | |
| Operating Income | $-263M | $-1.02B | $-249M | $-13.65B | $-266M | $-506M | $-80M | $-71M | $-75M | $-63M | $-56M | $-15M | |
| Interest Expense | · | $24M | $22M | $22M | $81M | · | · | · | · | · | · | · | |
| Interest Income | $37M | $57M | $47M | $13M | $776.0K | · | · | · | · | · | · | · | |
| Other Non-op | $10M | $-6M | $4M | $-859.0K | $5M | $-545.0K | $342.0K | · | · | · | · | · | |
| Pretax Income | $-236M | $-994M | $-220M | $-13.66B | $-385M | $-576M | $-109M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| Income Tax | $-35M | $8M | $760.0K | $-4M | $44M | $-91M | $-11M | $118.0K | $-225.0K | $510.0K | $36.0K | $388.0K | |
| Net Income | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | $-17M | |
| EPS (Basic) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| EPS (Diluted) | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 | $-5.36 | $-1.38 | · | · | · | · | · | |
| Shares (Basic) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| Shares (Diluted) | 176,221,530 | 170,564,088 | 164,578,219 | 161,457,123 | 156,939,349 | 90,509,229 | 71,844,535 | · | · | · | · | · | |
| EBITDA | $-263M | $-1.02B | $-249M | $-13.40B | $-61M | $-437M | $-80M | $-35M | $-56M | · | $-51M | · |
Bilanz 28
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $781M | $1.30B | $1.12B | $918M | $893M | $733M | $514M | $424M | $43M | $50M | $55M | $46M | |
| Short-term Investments | · | · | · | · | · | · | · | $55M | $79M | $16M | $82M | · | |
| Receivables | $193M | $214M | $217M | $211M | $169M | $169M | $57M | $44M | $27M | $14M | $12M | $7M | |
| Inventory | $38M | $38M | $30M | $56M | $73M | $56M | $0 | · | · | · | · | · | |
| Prepaid Expense | $107M | $113M | $118M | $130M | $87M | $47M | $14M | $11M | $7M | $3M | $2M | $966.0K | |
| Other Current Assets | $2M | $3M | $7M | $12M | $6M | · | · | · | · | · | · | · | |
| Current Assets | $1.12B | $1.66B | $1.49B | $1.32B | $1.23B | $1.06B | $588M | $533M | $156M | $83M | $152M | $54M | |
| PP&E (Net) | $27M | $29M | $32M | $30M | $27M | $29M | $10M | $10M | $9M | $7M | $6M | $1M | |
| PP&E (Gross) | $112M | $101M | $92M | $77M | $61M | $51M | $26M | $22M | $17M | $12M | $8M | $2M | |
| Accum. Depreciation | $85M | $71M | $60M | $48M | $34M | $22M | $16M | $12M | $8M | $4M | $2M | $1M | |
| Goodwill | $283M | $283M | $1.07B | $1.07B | $14.50B | $14.58B | $746M | $737M | $499M | $188M | $56M | $28M | |
| Intangibles | $1.30B | $1.43B | $1.68B | $1.84B | $1.91B | $2.02B | $225M | $247M | $160M | $25M | $15M | $8M | |
| Other Non-current Assets | $106M | $81M | $80M | $49M | $21M | $18M | $7M | $1M | $858.0K | $415.0K | $293.0K | $296.0K | |
| Total Assets | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Accounts Payable | $48M | $33M | $44M | $48M | $47M | $46M | $9M | $8M | $4M | $2M | $2M | $2M | |
| Current Liabilities | $405M | $942M | $421M | $400M | $331M | $333M | $90M | $62M | $40M | $21M | $18M | $10M | |
| Capital Leases | $34M | $32M | $43M | $38M | $42M | $43M | $25M | $0 | · | · | · | · | |
| Deferred Tax | $29M | $50M | $49M | $51M | $76M | $102M | $22M | $32M | $13M | $2M | $1M | $482.0K | |
| Other Non-current Liabilities | $643.0K | $720.0K | $1M | $2M | $1M | $2M | $9M | $6M | $5M | $8M | $7M | $3M | |
| Total Liabilities | $1.47B | $2.03B | $2.07B | · | · | · | · | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | $44M | $26M | $26M | |
| Total Debt | · | · | · | · | $0 | $43M | · | · | · | · | $26M | · | |
| Common Stock | $178.0K | $173.0K | $167.0K | $163.0K | $160.0K | $150.0K | $73.0K | $70.0K | $61.0K | $46.0K | $38.0K | $2.0K | |
| Retained Earnings | $-16.43B | $-16.23B | $-15.23B | $-15.01B | $-1.42B | $-993M | $-508M | $-409M | $-312M | $-205M | $-131M | $-72M | |
| AOCI | $-35M | $-38M | $-37M | $-43M | $-6M | $19M | $-17M | $-13M | $4M | $-1.0K | $-42.0K | · | |
| Stockholders' Equity | $1.39B | $1.49B | $2.33B | $2.31B | $16.05B | $15.88B | $1.01B | $1.01B | $559M | $231M | $179M | $-68M | |
| Liabilities + Equity | $2.86B | $3.52B | $4.39B | $4.35B | $17.73B | $17.76B | $1.60B | $1.53B | $824M | $304M | $230M | $92M | |
| Shares Outstanding | 178,315,400 | 173,405,016 | 166,658,253 | 162,840,360 | 160,469,325 | 150,281,099 | 72,761,941 | 70,516,249 | 61,534,101 | 46,201,563 | 38,524,922 | 2,037,999 |
Cashflow 18
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | $256M | $204M | $69M | $39M | $36M | $19M | $8M | $5M | $2M | |
| Stock-based Comp | $80M | $146M | $202M | $218M | $303M | $476M | $67M | $44M | $31M | $8M | $3M | $533.0K | |
| Deferred Tax | $-41M | $-1M | $-2M | $-8M | $41M | $-91M | $-11M | $-2M | $-591.0K | $510.0K | $36.0K | $388.0K | |
| Amort. of Intangibles | $351M | $363M | $326M | $245M | $195M | $65M | $36M | $32M | $15M | $6M | $4M | $2M | |
| Restructuring | $19M | $20M | $17M | $7M | · | · | · | $1M | · | · | · | · | |
| Other Non-cash | · | · | · | $13.38B | $75M | $-23M | · | $15M | $23M | · | $3M | · | |
| Operating Cash Flow | $294M | $294M | $350M | $189M | $194M | $-54M | $30M | $-5M | $-34M | $-52M | $-47M | $-11M | |
| CapEx | $9M | $11M | $11M | $16M | $9M | $4M | $4M | $4M | $3M | $2M | $6M | $1M | |
| Investing Cash Flow | $-266M | $-124M | $-156M | $-168M | $-73M | $-591M | $25M | $-257M | $-448M | $26M | $-108M | · | |
| Debt Issued | · | · | · | · | · | · | · | $10.0K | $167M | $35M | $7M | $20M | |
| Net Debt Issued | · | · | · | · | · | · | $0 | $10.0K | $-60M | · | $468.0K | · | |
| Stock Issued | · | · | · | · | · | $0 | $0 | $331M | $259M | $250.0K | $163M | · | |
| Stock Repurchased | · | · | · | · | · | · | · | · | · | · | · | $368.0K | |
| Net Stock Activity | · | · | · | · | · | $0 | $0 | $331M | $259M | · | · | · | |
| Financing Cash Flow | $-552M | $8M | $11M | $6M | $41M | $859M | $35M | $646M | $475M | $21M | $164M | · | |
| Taxes Paid | $9M | $9M | $7M | $3M | $4M | $1M | $1M | $441.0K | $137.0K | · | · | · | |
| Free Cash Flow | $285M | $283M | $339M | $173M | $185M | $-58M | $26M | $-9M | $-37M | · | $-53M | · | |
| Levered FCF | · | $259M | $316M | · | · | · | · | · | · | · | · | · |
Rentabilität 8
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | · | · | 69.2% | 73.6% | · | 72.8% | · | |
| Operating Margin | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% | -46.3% | -14.5% | -17.0% | -32.3% | · | -72.1% | · | |
| Net Margin | -7.9% | -39.0% | -8.5% | -567.5% | -21.1% | -44.4% | -17.9% | -23.2% | -45.8% | · | -75.0% | · | |
| Pretax Margin | -9.3% | -38.7% | -8.4% | -567.7% | -18.9% | -52.6% | -19.8% | -23.2% | -45.9% | · | -74.9% | · | |
| EBITDA Margin | -10.4% | -39.7% | -9.6% | -556.6% | -3.0% | -39.9% | -14.5% | -8.4% | -24.1% | · | -65.8% | · | |
| ROA | -6.3% | -25.3% | -5.0% | -123.7% | -2.4% | -5.0% | -6.3% | -8.2% | -18.9% | · | -36.1% | · | |
| ROE | -14.3% | -66.8% | -9.5% | -326.8% | -2.7% | -5.4% | -9.8% | -9.5% | -27.0% | · | -104.5% | · | |
| ROIC | -16.1% | -69.0% | -10.7% | -591.5% | -1.8% | -2.7% | -7.2% | -7.0% | -13.5% | · | -27.2% | · |
Liquidität & Solvenz 5
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 | 3.2 | 6.5 | 8.5 | 3.9 | · | 8.4 | · | |
| Quick Ratio | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 | 2.7 | 6.3 | 8.4 | 3.7 | · | 8.3 | · | |
| Debt / Equity | · | · | · | · | 0.0 | 0.0 | · | · | · | · | 0.1 | · | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | 0.1 | · | |
| Interest Coverage | · | -42.9 | -11.2 | · | · | · | · | · | · | · | · | · |
Effizienz 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.6 | 0.6 | 0.2 | 0.1 | 0.1 | 0.4 | 0.4 | 0.4 | · | 0.5 | · | |
| Inventory Turnover | · | · | · | 11.5 | 10.0 | 13.8 | · | · | · | · | · | · | |
| Receivables Turnover | 12.4 | 11.9 | 12.2 | 12.7 | 12.0 | 9.7 | 11.0 | 11.8 | 11.4 | · | 8.2 | · |
Wachstumsraten 3
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -1.5% | -1.3% | 8.1% | 18.4% | 85.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 1.7% | 8.1% | 33.5% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 18.3% | · | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM) 13
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B | $1.09B | $553M | $418M | $233M | $123M | $77M | · | |
| Net Income TTM | $-200M | $-1.00B | $-220M | $-13.66B | $-429M | $-485M | $-99M | $-97M | $-107M | $-74M | $-58M | · | |
| Market Cap | $1.25B | $1.58B | $3.59B | $3.85B | $14.73B | $30.05B | $6.09B | $3.50B | $2.14B | · | $692M | · | |
| Enterprise Value | · | · | · | · | $13.84B | $29.36B | · | · | · | · | $581M | · | |
| P/E | -6.1 | -1.5 | -16.1 | -0.3 | -33.6 | -37.3 | -60.7 | · | · | · | · | · | |
| P/S | 0.5 | 0.6 | 1.4 | 1.6 | 7.2 | 27.5 | 11.0 | 8.4 | 9.2 | · | 8.9 | · | |
| P/B | 0.9 | 1.1 | 1.5 | 1.7 | 0.9 | 1.9 | 6.0 | 3.5 | 3.8 | · | 3.9 | · | |
| P / Cash Flow | 4.2 | 5.4 | 10.3 | 20.3 | 76.0 | -561.6 | 203.9 | -719.2 | -62.3 | · | -14.7 | · | |
| P / FCF | 4.4 | 5.6 | 10.6 | 22.3 | 79.4 | -522.3 | 231.1 | -394.0 | -57.8 | · | -12.9 | · | |
| EV / EBITDA | · | · | · | · | -225.4 | -67.2 | · | · | · | · | -11.4 | · | |
| EV / FCF | · | · | · | · | 74.6 | -510.3 | · | · | · | · | -10.9 | · | |
| EV / Revenue | · | · | · | · | 6.8 | 26.8 | · | · | · | · | 7.5 | · | |
| Earnings Yield | -16.3% | -64.6% | -6.2% | -357.7% | -3.0% | -2.7% | -1.7% | · | · | · | · | · |
Gewinn- und Verlustrechnung 17
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $607M | $614M | $642M | $626M | $632M | $629M | $640M | $641M | $642M | $646M | $661M | $660M | $652M | $629M | $638M | $611M | |
| Cost of Revenue | · | · | · | · | · | · | · | · | · | · | · | · | $191M | $190M | · | $186M | |
| R&D Expense | $63M | $68M | $72M | $68M | $69M | $70M | $77M | $72M | $77M | $81M | $90M | $84M | $87M | $87M | $83M | $85M | |
| SG&A Expense | $104M | $102M | $108M | $103M | $108M | $113M | $100M | $114M | $110M | $112M | $109M | $116M | $126M | $114M | $120M | $112M | |
| Operating Expenses | $644M | $676M | $678M | $678M | $686M | $750M | $689M | $685M | $1.48B | $733M | $696M | $725M | $724M | $706M | $4.45B | $683M | |
| Operating Income | $-37M | $-62M | $-36M | $-52M | $-54M | $-121M | $-48M | $-44M | $-841M | $-87M | $-35M | $-65M | $-72M | $-77M | $-3.82B | $-72M | |
| Interest Expense | · | · | · | · | · | $6M | · | $6M | $6M | $6M | · | $6M | $6M | $5M | $5M | $6M | |
| Interest Income | $6M | $6M | $7M | $7M | $10M | $13M | $14M | $15M | $14M | $14M | $14M | $13M | $12M | $9M | $6M | $5M | |
| Other Non-op | $-2M | $-196.0K | $378.0K | $-815.0K | $8M | $2M | $-7M | $2M | $-563.0K | $-370.0K | $2M | $-2M | $-207.0K | $5M | $2M | $-2M | |
| Pretax Income | $-38M | $-61M | $-34M | $-50M | $-40M | $-111M | $-48M | $-32M | $-834M | $-79M | $-25M | $-60M | $-66M | $-69M | $-3.81B | $-75M | |
| Income Tax | $997.0K | $3M | $-8M | $-715.0K | $-8M | $-18M | $238.0K | $780.0K | $4M | $3M | $4M | $-2M | $-952.0K | $681.0K | $-2M | $-1M | |
| Net Income | $-39M | $-64M | $-25M | $-50M | $-33M | $-93M | $-48M | $-33M | $-838M | $-82M | $-29M | $-57M | $-65M | $-69M | $-3.81B | $-73M | |
| EPS (Basic) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| EPS (Diluted) | $-0.21 | $-0.36 | $-0.14 | $-0.28 | $-0.19 | $-0.53 | $-0.27 | $-0.19 | $-4.92 | $-0.49 | $-0.17 | $-0.35 | $-0.40 | $-0.42 | $-23.35 | $-0.45 | |
| Shares (Basic) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| Shares (Diluted) | 181,026,004 | 179,122,268 | -350,784,759 | 176,934,781 | 175,917,380 | 174,154,128 | -338,892,523 | 171,496,282 | 170,229,583 | 167,730,746 | -327,635,223 | 165,119,379 | 164,171,372 | 162,922,691 | -322,180,835 | 161,727,962 | |
| EBITDA | $-37M | $-62M | · | $-52M | $-54M | $-121M | · | $-44M | $-841M | $-87M | · | $30M | $4M | $-7M | · | $-72M |
Bilanz 25
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $774M | $751M | $781M | $726M | $680M | $1.19B | $1.30B | $1.24B | $1.16B | $1.10B | · | $1.03B | $959M | $889M | · | $900M | |
| Receivables | $221M | $214M | $193M | $211M | $225M | $233M | $214M | $212M | $218M | $214M | · | $206M | $215M | $216M | · | $202M | |
| Inventory | $29M | $32M | $38M | $40M | $38M | $38M | $38M | $37M | $35M | $32M | · | $36M | $34M | $46M | · | $59M | |
| Prepaid Expense | $124M | $136M | $107M | $116M | $130M | $138M | $113M | $116M | $131M | $142M | · | $115M | $113M | $136M | · | $127M | |
| Other Current Assets | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $983.0K | $6M | $9M | · | $8M | $8M | $7M | · | $13M | |
| Current Assets | $1.15B | $1.13B | $1.12B | $1.09B | $1.07B | $1.60B | $1.66B | $1.61B | $1.55B | $1.49B | · | $1.39B | $1.32B | $1.29B | · | $1.29B | |
| PP&E (Net) | $25M | $26M | $27M | $27M | $28M | $31M | $29M | $28M | $29M | $30M | · | $33M | $30M | $30M | · | $27M | |
| PP&E (Gross) | · | · | $112M | · | · | · | $101M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $85M | · | · | · | $71M | · | · | · | · | · | · | · | · | · | |
| Goodwill | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $283M | $1.07B | $1.07B | $1.07B | $1.07B | $1.07B | · | $4.85B | |
| Intangibles | $1.18B | $1.24B | $1.30B | $1.34B | $1.38B | $1.39B | $1.43B | $1.50B | $1.55B | $1.61B | · | $1.73B | $1.78B | $1.82B | · | $1.85B | |
| Other Non-current Assets | $104M | $106M | $106M | $107M | $101M | $109M | $81M | $78M | $81M | $80M | · | $74M | $73M | $64M | · | $44M | |
| Total Assets | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Accounts Payable | $37M | $45M | $48M | $52M | $54M | $52M | $33M | $38M | $56M | $38M | · | $26M | $16M | $39M | · | $71M | |
| Current Liabilities | $1.38B | $405M | $405M | $405M | $402M | $952M | $942M | $931M | $931M | $389M | · | $403M | $383M | $381M | · | $411M | |
| Capital Leases | $30M | $32M | $34M | $38M | $32M | $34M | $32M | $37M | $38M | $40M | · | $34M | $37M | $36M | · | $41M | |
| Deferred Tax | $27M | $28M | $29M | $34M | $30M | $24M | $50M | $51M | $51M | $47M | · | $44M | $48M | $51M | · | $52M | |
| Other Non-current Liabilities | $700.0K | $551.0K | $643.0K | $4M | $4M | $4M | $720.0K | $736.0K | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Total Liabilities | $1.45B | $1.47B | $1.47B | $1.49B | $1.47B | $2.02B | $2.03B | $2.02B | $2.02B | · | · | · | · | · | · | · | |
| Common Stock | $182.0K | $180.0K | $178.0K | $177.0K | $177.0K | $175.0K | $173.0K | $172.0K | $171.0K | $169.0K | · | $166.0K | $165.0K | $164.0K | · | $162.0K | |
| Retained Earnings | $-16.53B | $-16.49B | $-16.43B | $-16.41B | $-16.36B | $-16.32B | $-16.23B | $-16.18B | $-16.15B | $-15.31B | · | $-15.20B | $-15.14B | $-15.08B | · | $-11.20B | |
| AOCI | $-34M | $-35M | $-35M | $-35M | $-35M | $-37M | $-38M | $-37M | $-39M | $-39M | · | $-42M | $-39M | $-41M | · | $-49M | |
| Stockholders' Equity | $1.31B | $1.34B | $1.39B | $1.39B | $1.42B | $1.43B | $1.49B | $1.51B | $1.50B | $2.29B | $2.33B | $2.29B | $2.30B | $2.29B | $2.31B | $6.05B | |
| Liabilities + Equity | $2.76B | $2.81B | $2.86B | $2.88B | $2.89B | $3.44B | $3.52B | $3.53B | $3.52B | $4.32B | · | $4.33B | $4.32B | $4.31B | · | $8.10B | |
| Shares Outstanding | 181,649,591 | 180,431,102 | 178,315,400 | 177,349,640 | 176,608,056 | 175,340,325 | 173,405,016 | 171,944,014 | 171,124,883 | 169,314,029 | 166,658,253 | 165,557,305 | 164,877,180 | 163,919,394 | 162,840,360 | 162,195,790 |
Cashflow 12
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | · | · | · | · | $94M | $75M | $70M | · | $62M | |
| Stock-based Comp | $9M | $15M | $16M | $17M | $22M | $25M | $27M | $34M | $42M | $42M | $47M | $53M | $56M | $46M | $51M | $56M | |
| Amort. of Intangibles | $88M | $90M | $92M | $86M | $89M | $84M | $87M | $87M | $95M | $95M | $95M | $92M | $73M | $67M | $83M | $49M | |
| Restructuring | · | · | · | · | · | · | · | · | · | · | $6M | $411.0K | $3M | $8M | · | · | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | $-33M | · | · | |
| Operating Cash Flow | $65M | $10M | $88M | $99M | $91M | $16M | $86M | $110M | $89M | $9M | $130M | $106M | $101M | $13M | $66M | $63M | |
| CapEx | $928.0K | $2M | $3M | $2M | $1M | $3M | $6M | $2M | $2M | $1M | $1M | $6M | $2M | $2M | $6M | $4M | |
| Investing Cash Flow | $-42M | $-37M | $-34M | $-49M | $-60M | $-123M | $-30M | $-31M | $-28M | $-36M | $-37M | $-38M | $-37M | $-46M | $-54M | $-41M | |
| Financing Cash Flow | $875.0K | $-2M | $1M | $-4M | $-550M | $769.0K | $2M | $698.0K | $4M | $2M | $-2M | $5M | $4M | $3M | $4M | $634.0K | |
| Taxes Paid | $3M | $-42.0K | $3M | $104.0K | $5M | $328.0K | $2M | $3M | $5M | $-245.0K | $921.0K | $6M | $439.0K | $346.0K | $2M | $337.0K | |
| Free Cash Flow | · | $8M | · | · | · | $13M | · | · | · | $8M | · | · | · | $11M | · | · | |
| Levered FCF | · | · | · | · | · | $8M | · | · | · | $2M | · | · | · | · | · | · |
Rentabilität 7
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | -9.8% | -11.0% | -12.2% | · | -11.7% | |
| Net Margin | -6.4% | -10.4% | · | -7.9% | -5.2% | -14.8% | · | -5.2% | -130.4% | -12.7% | · | -8.6% | -10.0% | -11.0% | · | -12.0% | |
| Pretax Margin | -6.2% | -9.9% | · | -8.0% | -6.4% | -17.7% | · | -5.1% | -129.8% | -12.3% | · | -9.0% | -10.1% | -10.9% | · | -12.2% | |
| EBITDA Margin | -6.1% | -10.1% | · | -8.3% | -8.6% | -19.2% | · | -6.9% | -130.9% | -13.5% | · | 4.5% | 0.59% | -1.2% | · | -11.7% | |
| ROA | -1.4% | -2.0% | · | -1.6% | -1.0% | -2.4% | · | -0.85% | -21.4% | -1.9% | · | -0.92% | -1.1% | -0.90% | · | -0.57% | |
| ROE | -2.9% | -4.6% | · | -3.4% | -2.2% | -5.0% | · | -1.8% | -44.1% | -3.6% | · | -1.4% | -1.6% | -1.2% | · | -0.67% | |
| ROIC | -2.9% | -4.9% | · | -3.7% | -3.1% | -7.1% | · | -3.0% | -56.3% | -3.9% | · | -2.7% | -3.1% | -3.4% | · | -1.2% |
Liquidität & Solvenz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 2.8 | · | 2.7 | 2.7 | 1.7 | · | 1.7 | 1.7 | 3.8 | · | 3.4 | 3.4 | 3.4 | · | 3.1 | |
| Quick Ratio | 0.7 | 2.4 | · | 2.3 | 2.3 | 1.5 | · | 1.6 | 1.5 | 3.4 | · | 3.1 | 3.1 | 2.9 | · | 2.7 | |
| Interest Coverage | · | · | · | · | · | -20.9 | · | -7.8 | -148.9 | -15.4 | · | -11.5 | -12.3 | · | · | · |
Effizienz 3
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.0 | |
| Inventory Turnover | · | · | · | · | · | · | · | · | · | · | · | · | 4.0 | 3.3 | · | 3.2 | |
| Receivables Turnover | 2.7 | 2.7 | · | 3.0 | 2.8 | 2.8 | · | 3.1 | 3.0 | 3.0 | · | 3.2 | 3.1 | 3.1 | · | 3.2 |
Bewertung (TTM) 9
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.48B | $2.50B | · | $2.53B | $2.54B | $2.56B | · | $2.59B | $2.60B | $2.59B | · | $2.55B | $2.49B | $2.40B | · | $2.29B | |
| Net Income TTM | $-185M | $-239M | · | $-208M | $-997M | $-1.05B | · | $-1.01B | $-1.04B | $-273M | · | $-265M | $-3.31B | $-9.92B | · | $-9.93B | |
| Market Cap | $1.54B | $983M | · | $1.37B | $1.54B | $1.40B | · | $1.58B | $1.67B | $2.56B | · | $3.08B | $4.17B | $4.25B | · | $4.11B | |
| P/E | -8.2 | -4.0 | · | -6.5 | -1.5 | -1.3 | · | -1.5 | -1.6 | -9.1 | · | -11.5 | -1.2 | -0.4 | · | -0.4 | |
| P/S | 0.6 | 0.4 | · | 0.5 | 0.6 | 0.5 | · | 0.6 | 0.6 | 1.0 | · | 1.2 | 1.7 | 1.8 | · | 1.8 | |
| P/B | 1.2 | 0.7 | · | 1.0 | 1.1 | 1.0 | · | 1.0 | 1.1 | 1.1 | · | 1.3 | 1.8 | 1.9 | · | 0.7 | |
| P / Cash Flow | · | 103.3 | · | · | · | 87.7 | · | · | · | 286.6 | · | · | · | 322.7 | · | · | |
| P / FCF | · | 125.2 | · | · | · | 105.8 | · | · | · | 329.0 | · | · | · | 393.4 | · | · | |
| Earnings Yield | -12.3% | -24.9% | · | -15.4% | -66.9% | -77.0% | · | -64.8% | -63.0% | -11.0% | · | -8.7% | -80.9% | -238.1% | · | -243.7% |
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
Gewinn- und Verlustrechnung
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Umsatz | $2.53B | $2.57B | $2.60B | $2.41B | $2.03B |
| Betriebsgewinnmarge % | -10.4% | -39.7% | -9.6% | -567.3% | -13.1% |
| Nettoergebnis | $-200M | $-1.00B | $-220M | $-13.66B | $-429M |
| Verwässerte EPS | $-1.14 | $-5.87 | $-1.34 | $-84.60 | $-2.73 |
Bilanz
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | — | — | — | — | 0.0 |
| Liquiditätsgrad | 2.8 | 1.8 | 3.5 | 3.3 | 3.7 |
| Quick Ratio | 2.4 | 1.6 | 3.2 | 2.8 | 3.2 |
Cashflow
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Freier Cashflow | $285M | $283M | $339M | $173M | $185M |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
📊
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das ➕ neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Institutionelle Eigentümer (13F) 398 Einreicher · $1.2B gesamt · Stand 30. Juni 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 73 (+11 vs. Vorquartal) | 33 (-40 vs. Vorquartal) | 104 (-10 vs. Vorquartal) | 88 (+3 vs. Vorquartal) | +36.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $139.930.938 | 19.990.134 | 11,50% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $107.573.820 | 12.685.592 | 8,84% | Aktien |
| Point72 Asset Management, L.P. | $69.874.581 | 8.239.927 | 5,74% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $68.457.700 | 8.072.842 | 5,63% | Aktien |
| Voss Capital, LP | $68.235.838 | 8.046.679 | 5,61% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $67.458.671 | 7.955.032 | 5,55% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $59.415.442 | 7.006.538 | 4,88% | Aktien |
| STATE STREET CORP | $42.080.999 | 4.962.382 | 3,46% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $41.505.394 | 4.894.504 | 3,41% | Aktien |
| Allianz Asset Management GmbH | $39.572.734 | 4.666.596 | 3,25% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $33.651.520 | 3.967.415 | 2,77% | Aktien |
| Monaco Asset Management SAM | $26.864.462 | 3.167.979 | 2,21% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $26.370.375 | 3.109.714 | 2,17% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $25.976.377 | 3.063.252 | 2,14% | Aktien |
| GOLDMAN SACHS GROUP INC | $25.430.579 | 2.998.889 | 2,09% | Aktien |
| Quantinno Capital Management LP | $23.904.416 | 2.818.917 | 1,97% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $17.299.632 | 2.040.051 | 1,42% | Aktien |
| AMERIPRISE FINANCIAL INC | $16.946.398 | 1.998.396 | 1,39% | Aktien |
| Pale Fire Capital SE | $16.737.502 | 1.973.762 | 1,38% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $16.435.088 | 1.938.100 | 1,35% | Kaufoption |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.710.032 | 1.380.900 | 0,96% | Verkaufsoption |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $11.348.708 | 1.338.291 | 0,93% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $10.120.074 | 1.193.405 | 0,83% | Aktien |
| BNP PARIBAS FINANCIAL MARKETS | $9.796.800 | 1.155.283 | 0,81% | Aktien |
| Freestone Grove Partners LP | $7.338.160 | 865.349 | 0,60% | Aktien |
| Man Group plc | $6.880.545 | 811.385 | 0,57% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $6.795.228 | 801.324 | 0,56% | Aktien |
| CITADEL ADVISORS LLC | $6.795.024 | 801.300 | 0,56% | Verkaufsoption |
| Union Square Park Capital Management, LLC | $6.784.000 | 800.000 | 0,56% | Aktien |
| CITADEL ADVISORS LLC | $6.532.093 | 770.294 | 0,54% | Aktien |
| FMR LLC | $6.418.334 | 756.879 | 0,53% | Aktien |
| TCW GROUP INC | $6.248.039 | 736.797 | 0,51% | Aktien |
| Voss Capital, LP | $5.936.000 | 700.000 | 0,49% | Kaufoption |
| Empowered Funds, LLC | $5.764.619 | 679.790 | 0,47% | Aktien |
| PEAK6 LLC | $5.227.920 | 616.500 | 0,43% | Kaufoption |
| CITADEL ADVISORS LLC | $5.114.288 | 603.100 | 0,42% | Kaufoption |
| Squarepoint Ops LLC | $5.089.696 | 600.200 | 0,42% | Kaufoption |
| JANE STREET GROUP, LLC | $5.088.848 | 600.100 | 0,42% | Verkaufsoption |
| FRANKLIN RESOURCES INC | $4.518.161 | 532.802 | 0,37% | Aktien |
| TWO SIGMA ADVISERS, LP | $4.211.319 | 601.617 | 0,35% | Aktien |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.700.706 | 436.404 | 0,30% | Aktien |
| WOLVERINE TRADING, LLC | $3.607.180 | 439.900 | 0,30% | Kaufoption |
| Parallax Volatility Advisers, L.P. | $3.392.000 | 400.000 | 0,28% | Kaufoption |
| TUDOR INVESTMENT CORP ET AL | $3.288.603 | 387.807 | 0,27% | Aktien |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $3.248.866 | 383.121 | 0,27% | Aktien |
| Swiss National Bank | $3.035.857 | 358.002 | 0,25% | Aktien |
| BANK OF AMERICA CORP /DE/ | $2.894.928 | 341.383 | 0,24% | Aktien |
| ALLIANCEBERNSTEIN L.P. | $2.781.435 | 510.355 | 0,23% | Aktien |
| Squarepoint Ops LLC | $2.761.936 | 325.700 | 0,23% | Verkaufsoption |
| Trexquant Investment LP | $2.755.932 | 324.992 | 0,23% | Aktien |
| D. E. Shaw & Co., Inc. | $2.544.000 | 300.000 | 0,21% | Verkaufsoption |
| ORACLE INVESTMENT MANAGEMENT INC | $2.480.366 | 354.338 | 0,20% | Aktien |
| Soviero Asset Management, LP | $2.442.240 | 288.000 | 0,20% | Kaufoption |
| D. E. Shaw & Co., Inc. | $2.371.941 | 279.710 | 0,20% | Aktien |
| BlackRock, Inc. | $2.312.106 | 272.654 | 0,19% | Aktien |
| IEQ CAPITAL, LLC | $2.273.165 | 268.062 | 0,19% | Aktien |
| JANE STREET GROUP, LLC | $2.155.616 | 254.200 | 0,18% | Kaufoption |
| WOLVERINE TRADING, LLC | $2.059.020 | 251.100 | 0,17% | Verkaufsoption |
| RHUMBLINE ADVISERS | $2.058.803 | 242.785 | 0,17% | Aktien |
| Walleye Trading LLC | $2.017.188 | 237.876 | 0,17% | Aktien |
| WINTON GROUP Ltd | $1.925.808 | 227.100 | 0,16% | Aktien |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | $1.906.796 | 224.858 | 0,16% | Aktien |
| Brevan Howard Capital Management LP | $1.880.084 | 221.708 | 0,15% | Aktien |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $1.704.675 | 243.525 | 0,14% | Aktien |
| UBS Group AG | $1.696.000 | 200.000 | 0,14% | Kaufoption |
| NOMURA HOLDINGS INC | $1.696.000 | 200.000 | 0,14% | Verkaufsoption |
| Parker Investment Management, LLC | $1.586.515 | 187.089 | 0,13% | Aktien |
| OPPENHEIMER & CO INC | $1.571.268 | 185.291 | 0,13% | Aktien |
| ABS Direct Equity Fund LLC | $1.513.154 | 178.438 | 0,12% | Aktien |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.495.703 | 274.441 | 0,12% | Aktien |
| Summit Trail Advisors, LLC | $1.488.766 | 175.562 | 0,12% | Aktien |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | $1.484.000 | 175.000 | 0,12% | Aktien |
| SIMPLEX TRADING, LLC | $1.396.808 | 164.718 | 0,11% | Aktien |
| BARCLAYS PLC | $1.347.861 | 158.946 | 0,11% | Aktien |
| NATIXIS | $1.347.472 | 158.900 | 0,11% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.346.183 | 158.748 | 0,11% | Aktien |
| JENNISON ASSOCIATES LLC | $1.333.793 | 157.287 | 0,11% | Aktien |
| Rock Creek Group LLC | $1.329.944 | 156.833 | 0,11% | Aktien |
| MACKENZIE FINANCIAL CORP | $1.297.381 | 152.993 | 0,11% | Aktien |
| Walleye Trading LLC | $1.277.936 | 150.700 | 0,11% | Verkaufsoption |
| Counterpoint Mutual Funds LLC | $1.252.301 | 147.677 | 0,10% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.233.111 | 145.414 | 0,10% | Aktien |
| Balyasny Asset Management L.P. | $1.226.208 | 144.600 | 0,10% | Verkaufsoption |
| TWO SIGMA INVESTMENTS, LP | $1.217.245 | 143.543 | 0,10% | Aktien |
| ALGERT GLOBAL LLC | $1.211.792 | 142.900 | 0,10% | Aktien |
| Engineers Gate Manager LP | $1.204.499 | 142.040 | 0,10% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $1.187.666 | 140.055 | 0,10% | Aktien |
| Walleye Capital LLC | $1.082.896 | 127.700 | 0,09% | Kaufoption |
| Leonteq Securities AG | $1.064.384 | 125.517 | 0,09% | Aktien |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.045.813 | 123.327 | 0,09% | Aktien |
| JANUS HENDERSON GROUP PLC | $1.038.988 | 190.640 | 0,09% | Aktien |
| Walleye Capital LLC | $989.616 | 116.700 | 0,08% | Verkaufsoption |
| Crawford Fund Management, LLC | $987.072 | 116.400 | 0,08% | Verkaufsoption |
| OP Asset Management Ltd | $958.969 | 113.086 | 0,08% | Aktien |
| Vanguard Global Advisers, LLC | $932.469 | 109.961 | 0,08% | Aktien |
| CHIRON CAPITAL MANAGEMENT, LLC | $930.850 | 109.770 | 0,08% | Aktien |
| Jefferies Financial Group Inc. | $907.657 | 107.035 | 0,07% | Aktien |
| MetLife Investment Management, LLC | $901.746 | 106.338 | 0,07% | Aktien |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $891.845 | 96.104 | 0,07% | Aktien |
| Y-Intercept (Hong Kong) Ltd | $876.815 | 103.398 | 0,07% | Aktien |
Unternehmensinsider 48 Insider · 23 Führungskräfte · 22 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Charles Divita III | CHIEF EXECUTIVE OFFICER | 10. Juni 2026 M | 414.622 | 0 | 6 | $-938.572 |
| Jason N Gorevic | Chief Executive Officer | 4. März 2022 M | 516.464 | 0 | 0 | $0 |
| Mala Murthy | Chief Financial Officer | 1. März 2022 A | 17.357 | 0 | 0 | $0 |
| Mark Hirschhorn | Executive VP, COO and CFO | 13. Dezember 2018 M | 10.000 | 0 | 0 | $0 |
| Kelly Bliss | President, U.S. Group Health | 6. Juli 2026 S | 84.878 | 0 | 4 | $-126.068 |
| Fernando M. Rodrigues | President of BetterHelp | 3. Juni 2026 S | 0 | 0 | 2 | $-114.131 |
| Carlos Nueno | President, International | 1. Juni 2026 M | 57.671 | 0 | 1 | $-47.257 |
| Peter A Mcclennen | President | 15. Juli 2019 M | 0 | 0 | 0 | $0 |
| David William Sides | Chief Operating Officer | 29. Juli 2021 M | 11.031 | 0 | 0 | $0 |
| Joseph Ronald Catapano | Chief Accounting Officer | 1. Juli 2026 M | 12.267 | 0 | 2 | $-8.108 |
| Adam C Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | 1. Juni 2026 M | 110.261 | 0 | 3 | $-241.831 |
| Daniel Trencher | SVP Corporate Strategy | 4. März 2022 M | 29.408 | 0 | 0 | $0 |
| Stephany Verstraete | Chief Marketing Officer | 4. März 2022 M | 31.828 | 0 | 0 | $0 |
| Andrew Turitz | SVP - Business Development | 4. März 2022 M | 14.794 | 0 | 0 | $0 |
| Claus Torp Jensen | Chief Innovation Officer | 1. März 2022 A | — | 0 | 0 | $0 |
| Arnnon Geshuri | Chief Human Resources Officer | 1. März 2022 A | 83.168 | 0 | 0 | $0 |
| Richard J Napolitano | Chief Accounting Officer | 1. März 2022 A | 1.195 | 0 | 0 | $0 |
| Lewis Levy | Chief Medical Officer | 1. Oktober 2020 M | 8.766 | 0 | 0 | $0 |
| Michelle Bucaria | Chief Human Resources Officer | 1. September 2020 M | 3.232 | 0 | 0 | $0 |
| Christopher Caridi | Chief Accounting Officer | 1. Juli 2020 A | — | 0 | 0 | $0 |
| Gabriel R. Cappucci | Senior VP, Controller and CAO | 16. April 2020 M | 988 | 0 | 0 | $0 |
| Michael H. King | Chief Sales Officer | 25. Mai 2017 A | 61.459 | 0 | 0 | $0 |
| Peter N. Nieves | EVP and CRO | 13. März 2017 A | — | 0 | 0 | $0 |
| Mark V Anquillare | Direktor | 3. August 2026 A | — | 0 | 0 | $0 |
| David B Snow JR | Direktor | 21. Mai 2026 A | 113.032 | 0 | 0 | $0 |
| David L Shedlarz | Direktor | 21. Mai 2026 A | 61.266 | 0 | 0 | $0 |
| Susan R Salka | Direktor | 30. März 2026 A | — | 0 | 0 | $0 |
| Catherine Jacobson | Direktor | 18. Februar 2022 M | 1.468 | 0 | 0 | $0 |
| William H. Frist | Direktor | 15. September 2021 M | 12.918 | 0 | 0 | $0 |
| Karen L Daniel | Direktor | 25. August 2021 M | 41.915 | 0 | 0 | $0 |
| Christopher Bischoff | Direktor | 25. Mai 2021 M | 5.121 | 0 | 0 | $0 |
| Mark Douglas Smith | Direktor | 17. Mai 2021 A | 3.536 | 0 | 0 | $0 |
| Kenneth H Paulus | Direktor | 17. Mai 2021 A | 0 | 0 | 0 | $0 |
| Thomas Mckinley | Direktor | 17. Mai 2021 A | 5.879 | 0 | 0 | $0 |
| Hemant Taneja | Direktor | 19. April 2021 S | 118.760 | 0 | 0 | $0 |
| Glen Tullman | Direktor | 1. April 2021 M | 275.793 | 0 | 0 | $0 |
| Helen Darling | Direktor | 11. Juni 2020 M | 918 | 0 | 0 | $0 |
| Arneek Multani | Direktor | 30. Mai 2019 A | 918 | 0 | 0 | $0 |
| Brian P Mcandrews | Direktor | 30. Mai 2019 A | 1.965 | 0 | 0 | $0 |
| Tom Mawhinney | Direktor | 25. Mai 2018 M | 46.203 | 0 | 0 | $0 |
| Martin R Felsenthal | Direktor | 8. August 2016 A | 10.860 | 0 | 0 | $0 |
| Dana G Mead Jr. | Direktor | 8. August 2016 A | 202 | 0 | 0 | $0 |
| James K Outland | Direktor | 13. Juli 2015 M | 49.986 | 0 | 0 | $0 |
| CHP III Management, L.L.C. | 10%-Eigentümer | 26. April 2017 J | 2.480.468 | 0 | 0 | $0 |
| CHP III LP | 10%-Eigentümer | 26. April 2017 J | 2.480.468 | 0 | 0 | $0 |
| Sandra L Fenwick | — | 21. Mai 2026 A | 10.762 | 0 | 0 | $0 |
| Yulun Wang | — | 25. Januar 2021 S | 219.507 | 0 | 0 | $0 |
| Michael Goldstein | — | 11. Juni 2020 M | 0 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Kinnevik AB (publ), Invik S.A. ×3 Einreichungen | 15. April 2021 | — | Erste Einreichung | — | SEC |
| General Catalyst Group Management Holdings GP, LLC, General Catalyst Group Management Holdings, L.P., General Catalyst Group Management, LLC, General Catalyst Group VI, L.P., General Catalyst Partners VI, L.P., General Catalyst GP VI, LLC, General Catalyst Group VIII, L.P., General Catalyst Group VIII Supplemental, L.P., General Catalyst Partners VIII, L.P., General Catalyst GP VIII, LLC, GC Partners Holdings, LP, GCSE VIII, L.P., GCSE VIII, LLC, GCGM Investment Holdings, LP, Kenneth I. Chenault, Joel E. Cutler, David P. Fialkow, Hemant Taneja ×3 Einreichungen | 16. März 2021 | — | Erste Einreichung | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF-Besitz Gehalten von 55 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| HEAL · Global X Funds | 1,18% | 38.782 NS | 31. Mai 2026 | N-PORT |
| SVAL · iShares Trust | 0,42% | 129.925 SH | 8. August 2026 | Täglich |
| JSML · Janus Detroit Street Trust | 0,34% | 178.607 NS | 30. April 2026 | N-PORT |
| GSSC · Goldman Sachs ETF Trust | 0,20% | 261.035 NS | 31. Mai 2026 | N-PORT |
| FSCC · Federated Hermes ETF Trust | 0,18% | 66.764 NS | 31. Mai 2026 | N-PORT |
| IHF · iShares Trust | 0,18% | 332.174 SH | 8. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,10% | 159.976 SH | 8. August 2026 | Täglich |
| SMLF · iShares Trust | 0,09% | 592.154 SH | 8. August 2026 | Täglich |
| FNDA · SCHWAB STRATEGIC TRUST | 0,08% | 978.669 NS | 31. Mai 2026 | N-PORT |
| AVUV · AMERICAN CENTURY ETF TRUST | 0,08% | 2.910.344 NS | 31. Mai 2026 | N-PORT |
| IWN · iShares Trust | 0,08% | 1.690.654 SH | 8. August 2026 | Täglich |
| GINN · Goldman Sachs ETF Trust | 0,08% | 21.242 NS | 31. Mai 2026 | N-PORT |
| DFSV · Dimensional ETF Trust | 0,07% | 920.742 NS | 30. April 2026 | N-PORT |
| NUSC · Nushares ETF Trust | 0,07% | 155.542 NS | 30. April 2026 | N-PORT |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,07% | 252.145 NS | 31. Mai 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 67.673 NS | 30. April 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,05% | 1.047.849 SH | 8. August 2026 | Täglich |
| VFMF · VANGUARD WELLINGTON FUND | 0,04% | 29.737 SH | 8. August 2026 | Täglich |
| IWM · iShares Trust | 0,04% | 4.666.989 SH | 8. August 2026 | Täglich |
| ISCV · iShares Trust | 0,04% | 38.629 SH | 8. August 2026 | Täglich |
| PNQI · Invesco Exchange-Traded Fund Trust | 0,04% | 26.986 SH | 8. August 2026 | Täglich |
| ITWO · ProShares Trust | 0,03% | 8.377 NS | 31. Mai 2026 | N-PORT |
| RSSL · Global X Funds | 0,03% | 77.120 NS | 30. April 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 2.631.374 SH | 8. August 2026 | Täglich |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 858.463 NS | 31. Mai 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 584.184 NS | 30. April 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 2.084.219 SH | 8. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,02% | 4.153.113 SH | 8. August 2026 | Täglich |
| UWM · ProShares Trust | 0,02% | 6.552 NS | 31. Mai 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,02% | 535.056 SH | 8. August 2026 | Täglich |
| ISCB · iShares Trust | 0,02% | 7.717 SH | 8. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 81.058 NS | 30. April 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,02% | 10.585 NS | 30. April 2026 | N-PORT |
| URTY · ProShares Trust | 0,01% | 6.629 NS | 31. Mai 2026 | N-PORT |
| DFAT · Dimensional ETF Trust | 0,01% | 285.019 NS | 30. April 2026 | N-PORT |
| PRF · Invesco Exchange-Traded Fund Trust | 0,01% | 170.044 SH | 8. August 2026 | Täglich |
| WSML · iShares Trust | 0,01% | 10.387 SH | 8. August 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 34.034 NS | 30. April 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 6.863 NS | 31. Mai 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 166 NS | 31. Mai 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 422.235 NS | 30. April 2026 | N-PORT |
| FNDB · SCHWAB STRATEGIC TRUST | 0,01% | 9.970 NS | 31. Mai 2026 | N-PORT |
| AVUQ · AMERICAN CENTURY ETF TRUST | 0,01% | 1.783 NS | 31. Mai 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 22.871 NS | 30. April 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,00% | 11.743 NS | 30. April 2026 | N-PORT |
| DSI · iShares Trust | 0,00% | 25.216 SH | 8. August 2026 | Täglich |
| AVUS · AMERICAN CENTURY ETF TRUST | 0,00% | 42.456 NS | 31. Mai 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 105.579 NS | 31. Mai 2026 | N-PORT |
| ITOT · iShares Trust | 0,00% | 232.888 SH | 8. August 2026 | Täglich |
| IWV · iShares Trust | 0,00% | 45.271 SH | 8. August 2026 | Täglich |